Tests currently used to determine whether an unborn child has Down syndrome carry a small risk of miscarriage, but a new test for the genetic abnormality could solve that problem by getting results from a maternal blood sample. The test, expected on the market this year, analyzes fetal RNA and DNA in the maternal blood serum for specific genetic markers found on chromosome 21. The number of copies of each of these markers reveals whether the fetal DNA has an extra copy of the chromosome–the genetic variation that causes Down syndrome.
Cost: Not available
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
We should gene-sequence cave paintings to find out more about who made them
Standard archeological techniques can’t determine whether the prehistoric artists were hunter-gatherers or farmers. Analyzing the paintings’ surfaces with techniques from biology offers much more information about how they worked and when they lived.
A cell-killing strategy to slow aging passed its first test this year
Are tired-out cells what make people old? A new generation of drugs is designed to wipe them out.
More than 26 million people have taken an at-home ancestry test
The genetic genie is out of the bottle. And it’s not going back.